Altshuler Shaham’s CorMedix CRMD Stock Holding History

Altshuler Shaham’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.8K	Buy	772 +724	+1,508%	+$5.72K	﹤0.01%	277
2026 Q1	$1.78K	Buy	+48	New	+$355	﹤0.01%	403

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Altshuler Shaham's CRMD Position: Q2 2026 in Review

Altshuler Shaham increased its CorMedix (CRMD) stake by 1,508% in Q2 2026, buying an estimated $5.72K and bringing the position to 772 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Altshuler Shaham first reported a position in CRMD in Q1 2026 and has held it in 2 quarters since. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Altshuler Shaham held 772 shares of CorMedix worth $27.8K as of Q2 2026.
Altshuler Shaham bought 724 CorMedix shares in Q2 2026, an estimated $5.72K.
CorMedix made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #277 holding.
Altshuler Shaham first reported a position in CorMedix in Q1 2026 and has held it in 2 quarters since.
193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.